Abstract
We are glad to introduce you that the 2024 3rd International Conference on Modern Medicine Technology and Clinical Science (MMTCS 2024) was successfully held in Tokyo, Japan from August 17-18, 2024. This conference brought together innovative academics and industrial experts in the fields of modern medicine technology, pharmaceutical engineering, and clinical science and application to a common forum. The primary goal of the conference is to promote research and developmental activities, and another goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working all around the world. During the conference, the conference model was divided into three sessions, including oral presentations, keynote speeches, and Q & A discussion. All the papers have been processed to meet the requirements of international publication standard. We selected a bunch of high-quality papers and compiled them into proceedings after rigorously reviewing. We would like to express our sincere gratitude to the distinguished keynote speakers, as well as all the participants. We also want to thank the publisher for publishing the proceedings. May the readers could enjoy and gain some valuable knowledge from the MMTCS 2024 proceedings. We are expecting more and more experts and scholars from all over the world to join this international event next year. The Scientific Committee of MMTCS 2024 Tokyo, Japan
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Transactions on Materials, Biotechnology and Life Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.